These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25753245)

  • 41. Body mass index and C-peptide are important for the promptly differential diagnosis of maturity-onset diabetes from familial type 2 diabetes in outpatient clinic.
    Wu HX; Tang J; Li L; Liu SP; Zhou ZG; Yang JX; Yan DW; Zhou HD
    Endocr J; 2019 Apr; 66(4):309-317. PubMed ID: 30760653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
    Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
    Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maturity onset diabetes of the young: clinical characteristics, diagnosis and management.
    Kavvoura FK; Owen KR
    Pediatr Endocrinol Rev; 2012 Dec-2013 Jan; 10(2):234-42. PubMed ID: 23539835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maturity onset diabetes of the young and fibrin-related thrombosis risk.
    Sagar RC; Phoenix F; Thanabalasingham G; Naseem K; Ajjan RA; Owen KR
    Diab Vasc Dis Res; 2020; 17(6):1479164120963048. PubMed ID: 33334146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.
    Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The importance of combined NGS and MLPA genetic tests for differential diagnosis of maturity onset diabetes of the young.
    Komazec J; Zdravkovic V; Sajic S; Jesic M; Andjelkovic M; Pavlovic S; Ugrin M
    Endokrynol Pol; 2019; 70(1):28-36. PubMed ID: 30259503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cystatin C is not a good candidate biomarker for HNF1A-MODY.
    Nowak N; Szopa M; Thanabalasingham G; McDonald TJ; Colclough K; Skupien J; James TJ; Kiec-Wilk B; Kozek E; Mlynarski W; Hattersley AT; Owen KR; Malecki MT
    Acta Diabetol; 2013 Oct; 50(5):815-20. PubMed ID: 22350134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A decade of molecular genetic testing for MODY: a retrospective study of utilization in The Netherlands.
    Weinreich SS; Bosma A; Henneman L; Rigter T; Spruijt CM; Grimbergen AJ; Breuning MH; de Koning EJ; Losekoot M; Cornel MC
    Eur J Hum Genet; 2015 Jan; 23(1):29-33. PubMed ID: 24736738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY).
    Diren A; Demirci DK; Gul N; Karacanli B; Baykut A; Tutuncu Y; Ozturk O; Satman I; Yilmaz-Aydogan H
    In Vivo; 2022; 36(5):2490-2504. PubMed ID: 36099138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.
    Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
    Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes.
    Besser RE; Jones J; McDonald TJ; Smith R; Shepherd MH; Hattersley AT
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22787179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The unique clinical spectrum of maturity onset diabetes of the young type 3.
    Lebenthal Y; Fisch Shvalb N; Gozlan Y; Tenenbaum A; Tenenbaum-Rakover Y; Vaillant E; Froguel P; Vaxillaire M; Gat-Yablonski G
    Diabetes Res Clin Pract; 2018 Jan; 135():18-22. PubMed ID: 29107759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).
    McKinney JL; Cao H; Robinson JF; Metzger DL; Cummings E; Riddell DC; Sanderson SR; Pacaud D; Ho J; Hegele RA
    Clin Invest Med; 2004 Jun; 27(3):135-41. PubMed ID: 15305805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study.
    Ley SH; Hegele RA; Connelly PW; Harris SB; Mamakeesick M; Cao H; Gittelsohn J; Retnakaran R; Zinman B; Hanley AJ
    Cardiovasc Diabetol; 2010 Aug; 9():39. PubMed ID: 20716378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on clinical screening of maturity-onset diabetes of the young (MODY).
    Peixoto-Barbosa R; Reis AF; Giuffrida FMA
    Diabetol Metab Syndr; 2020; 12():50. PubMed ID: 32528556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels.
    Ping F; Fu J; Xiao X
    Front Endocrinol (Lausanne); 2022; 13():1024431. PubMed ID: 36387841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
    Kettunen JLT; Rantala E; Dwivedi OP; Isomaa B; Sarelin L; Kokko P; Hakaste L; Miettinen PJ; Groop LC; Tuomi T
    Diabetologia; 2022 Apr; 65(4):632-643. PubMed ID: 34951657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young.
    Tijardović M; Štambuk T; Juszczak A; Keser T; Gasperikova D; Novokmet M; Tjora E; Pape Medvidović E; Stanik J; Rasmus Njølstad P; Lauc G; Owen KR; Gornik O
    Diabetes Res Clin Pract; 2022 Mar; 185():109226. PubMed ID: 35122907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.